Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 64.35 -1.23 (-1.88%) Market Cap: 3.95 Bil Enterprise Value: 3.74 Bil PE Ratio: 0 PB Ratio: 357.50 GF Score: 60/100

Q3 2021 Rhythm Pharmaceuticals Inc Earnings Call Transcript

Nov 02, 2021 / 12:00PM GMT
Release Date Price: $12.9 (+6.61%)
Operator

Good day, and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter Financial Results Conference Call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, David Connolly with Rhythm Pharmaceuticals. Please go ahead.

David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications

Thank you, and good morning. I'm David Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via conference call, the accompanying slides can be accessed and controlled by going to the Events section of the Investors page on our website at ir.rhythmtx.com.

This morning, we issued a press release that provides our third quarter 2021 financial results and business update, which is available on our website. As listed on Slide 2, with me today here in Boston for the conference call are David Meeker, Chair, President and Chief Executive Officer of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot